Fonts Size

Change Color


Healthcare facilities are required to complete the Training Programme on Abu Dhabi Healthcare Guidelines for Health Media & Advertising System as mentioned in circular number 26/2023, for more information Click Here

DOH urges all healthcare and pharmaceutical facilities & Health professional to Adhere to the circular number(63\2021) by updating the details of the mobile number & e-mail address in order to receive all circulars & letters issued by DOH, for more information Click Here

areas for collaboration (RWE/Big Data, Diabetes, Immunology, Oncology and Rare Disease).

Janssen Collaboration on Data Science with Department of Health Abu Dhabi

Multicenter, Randomized, Double Blind, Parallel Placebo Controlled, Phase III Clinical Trial to Evaluate the Protective Efficacy, Safety and immunogenicity of Inactivated SARS-CoV-2 Vaccines in Healthy Population”

A Multi-center, Randomized, Double Blind, Placebo Controlled Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients

NUYAD collaboration will support the mission shared between the two organizations to improve the health of the local population

Collaboration to formalizing relations and to enrich medical research in the Emirate of Abu Dhabi.

Collaboration in cellular therapy clinical trials and to support clinical research and training and to ensure joint efforts in the field of knowledge transfer .

Interested in collaborating with our research and technology network to make a difference in patient's lives? Get in touch with us at: medical.research@doh.gov.ae

Subscribe for updates

Thanks for Subscribing

Last updated: 21 Jul 2024

Mobile For an optimal experience please
rotate your device to portrait mode